课题基金 / 基金详情

The Safety of Antipsychotic Drugs Among Children and Youth With Attention Deficit and Hyperactivity Disorder

The Safety of Antipsychotic Drugs Among Children and Youth With Attention Deficit and Hyperactivity Disorder
患有注意力缺陷和多动症的儿童和青少年抗精神病药物的安全性
批准号：
443941
负责人：
Filion Kristian B
金额：
$12.82万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-04-01 至 2023-04-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=443941&lang=en
关键词：
Attention Deficit Hyperactivity Disorder Cardiac Safety Children Cohort Study Comparative Safety Diabetes Drug Safety Obesity Pharmacoepidemiology Population Health

项目摘要

项目成果

Filion Kristian B的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Attention deficit hyperactivity disorder (ADHD) is a mental health disorder characterized by hyperactive and impulsive behaviors. Treatments include cognitive behavioral therapy and prescription drugs (e.g., Ritalin), which are prescribed when behavioral
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparative Effectiveness of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin for the Prevention of Micro- and Macrovascular Complications Among Patients with Type 1 Diabetes
Comparative Effectiveness and Safety of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin among Patients with Type 2 Diabetes
A population-based assessment of pharmacological treatments for gestational diabetes
A personalized dynamic blood pressure control plan for cardiovascular disease prevention among patients with hypertension at low cardiovascular disease risk.
海外基金